Drug-Induced Ocular Side Effects , 8th Edition
Written by global experts in the field of chemical- and drug-related ocular problems, Drug-Induced Ocular Side Effects, 8th Edition, provides need-to-know information on all aspects of ocular toxicology in one concise reference. This best-selling, user-friendly resource features a templated format, numerous full-color illustrations, and sweeping content updates throughout - all designed to eliminate uncertainty and ensure accurate diagnosis and treatment guidance.
- Provides comprehensive coverage of drugs' generic and trade names, primary uses, ocular and systemic side effects, and clinical significance.
- Features a unique side effect index, a new concise paperback format for portability, and clinical photos of ocular symptoms of adverse drug reactions.
- Covers dozens of new drugs used in the U.S. and internationally, as well as extensive updates to drug registry information to ensure access to the latest data.
- Includes expanded sections on how to follow patients with visual adverse drug reactions to chloroquine, hydroxychloroquine, isotretinoin, ethambutol, and more. Guidelines can be copied to use as patient handouts.
- Offers extensive discussions of principles of therapy, ocular drug delivery, methods to evaluate drug-induced visual side effects, and the role of electrophysiology and psychophysics.
- Provides the WHO classification system to help you determine whether a particular side effect is certain, probable, or likely to occur.
- Ideal for ophthalmologists, optometrists, and busy clinicians in primary care, emergency medicine, and more - anyone who needs quick, on-the-spot consultation on ocular toxicology.
- Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
|Author Informaiton||By Frederick T. Fraunfelder, MD, Professor Emeritus, Department of Ophthalmology; Founder, National Registry of Drug Induced Ocular Side Effects; Consultant, World Health Organization; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA and Frederick W. Fraunfelder, Jr., MD, M.B.A, Chairman and Roy E. Mason and Elizabeth Patee Mason Distinguished Professor of Ophthalmology, Department of Ophthalmology, Missouri University School of Medicine; Director, National Registry of Drug-Induced Ocular Side Effects; Consultant, World Health Organization; Director, Missouri University Health Care's Mason Eye Institute, Columbia, Missouri, USA|
|Table of Content||
Instructions to Users
Chapter 1: Anti-Infectives
Chapter 2: Agents Affecting the CNS
Chapter 3: Analgesics, Narcotic Antagonists and Agents Used to Treat Arthritis
Chapter 4: Agents Used in Anesthesia
Chapter 5: Gastrointestinal Agents
Chapter 6: Cardiac, Vascular, and Renal Agents
Chapter 7: Hormones and Agents Affecting Hormonal Mechanisms
Chapter 8: Agents Affecting Blood Formation and Coagulability
Chapter 9: Homeostatic and Nutrient Agents
Chapter 10: Agents Used to Treat Allergic and Neuromuscular Disorders
Chapter 11: Oncolytic Agents
Chapter 12: Heavy Metal Antagonists and Miscellaneous Agents
Chapter 13: Agents Used in the Management of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Chapter 14: Drugs Used in Ophthalmology
Chapter 15: Herbal Medicine and Dietary Supplements
Chapter 16: National Registry of Drug-Induced Ocular Side Effects
Chapter 17: Ocular Drug Delivery
|trim||235 x 191 (7 1/2 x 9 1/4)|